The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Register of Actionable Mutations (RATIONAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05918666
Recruitment Status : Recruiting
First Posted : June 26, 2023
Last Update Posted : June 26, 2023
Sponsor:
Collaborators:
Roche Pharma AG
AstraZeneca
Bayer
Bristol-Myers Squibb
Janssen, LP
Takeda
Amgen
Daiichi Sankyo
Eli Lilly and Company
Novartis
Clinical Research Technology S.r.l.
Information provided by (Responsible Party):
Federation of Italian Cooperative Oncology Groups

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 27, 2026
Estimated Study Completion Date : October 27, 2026
Publications: